Inventor
BUTERA JOHN A
US52 patents
⚠️ This page may combine multiple inventors who share the name “BUTERA JOHN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMERICAN HOME PROD
30 patentsUS6288099B1Sep 11, 2001
Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
AMERICAN HOME PROD48 citations96
US5532245AJul 2, 1996
Substituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compounds
AMERICAN HOME PROD41 citations96
US5466712ANov 14, 1995
Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones
AMERICAN HOME PROD49 citations96
US5403853AApr 4, 1995
Substituted N-aryl-1,2-diaminocyclobutene-3,4-diones
AMERICAN HOME PROD42 citations96
US5401753AMar 28, 1995
Substituted n-heteroaryl-1, 2-diaminocyclobutene-3, 3-diones
AMERICAN HOME PROD42 citations96
US5397790AMar 14, 1995
Substituted isoquinolinyl-1-2-diaminocyclobutene-3,4,-diones
AMERICAN HOME PROD53 citations96
US5354763AOct 11, 1994
Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
AMERICAN HOME PROD45 citations96
US5206252AApr 27, 1993
Thiadiazolyl-amino derivatives of benzopyrans and indanes
AMERICAN HOME PROD38 citations93
US5506252AApr 9, 1996
Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
AMERICAN HOME PROD42 citations92
US6376555B1Apr 23, 2002
4-substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones and analogs thereof as novel potassium channel openers
AMERICAN HOME PROD28 citations90
US5464867ANov 7, 1995
Diaminocyclobutene-3,4-diones
AMERICAN HOME PROD14 citations82
US5403854AApr 4, 1995
Substituted N-heteroaryl -1,2-diaminocyclobutene-3,4-diones
AMERICAN HOME PROD12 citations82
US5605909AFeb 25, 1997
Substituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compounds
AMERICAN HOME PROD5 citations74
US5225566AJul 6, 1993
Indazolanonyl derivative of benzopyran
AMERICAN HOME PROD7 citations74
US5202346AApr 13, 1993
Piperidinyl and piperazinyl derivatives
AMERICAN HOME PROD14 citations74
US4994459AFeb 19, 1991
Aryloxypropane substituted piperazine derivatives with antiarrhythmic and antifibrillatory activity
AMERICAN HOME PROD7 citations74
US5512585AApr 30, 1996
Diaminocyclobutene-3,4-diones
AMERICAN HOME PROD7 citations73
US6391902B2May 21, 2002
Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
AMERICAN HOME PROD5 citations63
US5254689AOct 19, 1993
Piperdinyl and piperazinyl derivatives
AMERICAN HOME PROD6 citations63
US5084463AJan 28, 1992
N-quinolinyl alkyl-substituted 1-aryloxy-2-propanolamine and propylamine derivatives possessing class III antiarrhythmic activity
AMERICAN HOME PROD5 citations63
US5846999ADec 8, 1998
Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones
AMERICAN HOME PROD2 citations62
US5536731AJul 16, 1996
Diaminocyclobutene-3,4-diones
AMERICAN HOME PROD3 citations62
US5536741AJul 16, 1996
Diaminocyclobutene-3,4-diones
AMERICAN HOME PROD3 citations62
US5530025AJun 25, 1996
Diaminocyclobutene-3,4-diones
AMERICAN HOME PROD3 citations62
US5780505AJul 14, 1998
Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones
AMERICAN HOME PROD3 citations60
US5763474AJun 9, 1998
Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones
AMERICAN HOME PROD6 citations60
US5179118AJan 12, 1993
Indazolanonyl derivatives of benzopyrans
AMERICAN HOME PROD1 citations52
US5104892AApr 14, 1992
Substituted benzimidazole derivatives possessing Class III antiarrhythmic activity
AMERICAN HOME PROD0 citations52
US6465523B1Oct 15, 2002
4-substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones and analogs thereof as novel potassium channel openers
AMERICAN HOME PROD1 citations50
US6462059B1Oct 8, 2002
4-substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones and analogs thereof as novel potassium channel openers
AMERICAN HOME PROD0 citations50
AGENEBIO INC
9 patentsUS11142529B2Oct 12, 2021
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC6 citations82
US10815242B2Oct 27, 2020
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC7 citations82
US10329301B2Jun 25, 2019
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC6 citations82
US11505555B2Nov 22, 2022
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC2 citations71
US11312721B2Apr 26, 2022
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC2 citations71
US12291535B2May 6, 2025
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC2 citations70
US12024525B2Jul 2, 2024
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC0 citations61
US11414425B2Aug 16, 2022
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC0 citations58
US12528819B2Jan 20, 2026
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC0 citations50
WYETH CORP
5 patentsUS6765021B2Jul 20, 2004
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
WYETH CORP11 citations72
US7253153B2Aug 7, 2007
Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof
WYETH CORP1 citations51
US7115620B2Oct 3, 2006
1,3-disubstituted-2-thioxo-imidazolidine-4,5-diones as potassium channel openers
WYETH CORP0 citations51
US7008636B2Mar 7, 2006
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
WYETH CORP0 citations50
US6451827B2Sep 17, 2002
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
WYETH CORP1 citations50
ZEALAND PHARMA AS
2 patentsWYETH LLC
2 patents(unassigned)
1 patentLARSEN BJARNE DUE
1 patentShowing the top 50 of 52 patents by PatentIndex Score.